LGBT Cancer Project

Fallopian Tube Cancer Clinical Trials

A listing of Fallopian Tube Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study evaluating GEN-1 for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Arizona

Arizona Oncology Associates
Phoenix Arizona

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Arizona Oncology Associates
Tucson Arizona

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Phoenix Arizona 85004

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Tucson Arizona

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

California

Sutter West Bay
San Francisco California

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Long Beach California

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Los Angeles California 90095

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Los Angeles California 90048

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Monterey California 93940

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

San Diego California 92093

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

San Francisco California 94115

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Stanford California 94305

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Colorado

Denver Colorado 80218

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Connecticut

New Haven Connecticut 06520

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

District of Columbia

Washington District of Columbia 20007

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Florida

SCRI Florida Cancer Specialists
West Palm Beach Florida

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Jacksonville Florida 32224

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Miami Florida 33136

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Miami Florida 33136

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Orlando Florida 32804

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Peritoneal Carcinomatosis or Fallopian Tube Cancer

Orlando Florida 32804

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Orlando Florida 32804

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Sarasota Florida 34239

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Georgia

Northside Hospital
Atlanta Georgia

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Memorial University Medical Center
Savannah Georgia 31404

GOG 0273: Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Atlanta Georgia 30342

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Augusta Georgia 30912

A clinical trial to evaluate treatments using Chemotherapy and Rucaparib for patients with Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Augusta Georgia 30912

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Gainesville Georgia 30501

Patients are needed to participate in a clinical research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Neoplasms

Illinois

University of Chicago
Chicago Illinois

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Northwestern University
Evanston Illinois

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Chicago Illinois

A clinical research study of COTI2

Chicago Illinois 60629

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Chicago Illinois 60637

Patients are needed to participate in a clinical research study of entinostat, avelumab and Placebo to evaluate Epithelial Ovarian Cancer, Peritoneal Cancer or Fallopian Tube Cancer

Chicago Illinois 60637

Patients are needed to participate in a clinical research study of niraparib and pembrolizumab, Triple-negative Breast Cancer or Ovarian Cancer (KEYNOTE-162)

Hinsdale Illinois 60521

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Hinsdale Illinois 60521

Patients are needed to participate in a clinical research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Neoplasms

Maywood Illinois 60153

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Indiana

IU Melvine and Bren Cancer Center
Indianapolis Indiana

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

St. Vincent Hospital
Indianapolis Indiana

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Franciscan St. Francis Health
Indianapolis Indiana

A Randomized, Open Label Study Comparing the Combination of YONDELIS® and DOXIL®/CAELYX® with DOXIL®/CAELYX® Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Indianapolis Indiana 46202

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Indianapolis Indiana 46184

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Iowa

Ames Iowa 50010

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer

Des Moines Iowa 50309

Patients are needed to participate in a clinical research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Neoplasms

Kentucky

Lexington Kentucky 40536

A Phase 3 clinical study for patients with Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer or Ovarian Cancer